Lakefront Biotherapeutics (LKFT) EPS (Basic) (2014 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly EPS (Basic) of $0.25 for Q1 2026, up 109.45% year-on-year from $0.12 in Q1 2025, and down 98.15% on a QoQ basis from $13.51 in Q4 2025.
Lakefront Biotherapeutics (LKFT) EPS (Basic) (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported EPS (Basic) for 13 consecutive years, with $0.25 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) rose 109.45% year-over-year to $0.25 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.77 (up 570.22% YoY) and the FY2025 annual result came in at $5.54, up 333.15% from the prior year.
- EPS (Basic) slipped to $0.25 in Q1 2026 per LKFT's latest filing, from $13.51 in the prior quarter.
- Over the last five years, EPS (Basic) for LKFT reached as high as $13.51 in Q4 2025 and fell as low as -$3.59 in Q4 2022.
- A 5-year average of $0.72 and a median of $0.16 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 294.57% — and 2025, when it jumped 2990.63%.
- Year by year, EPS (Basic) stood at -$3.59 in 2022, then soared by 175.83% to $2.72 in 2023, then plunged by 83.94% to $0.44 in 2024, then soared by 2990.63% to $13.51 in 2025, then sank by 98.15% to $0.25 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.25, $13.51, and $0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 13.51 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -2.65 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | -0.87 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 1.56 |
| Dec 31, 2023 | 2.72 |
| Sep 30, 2023 | 0.45 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | -3.59 |
| Sep 30, 2022 | 0.37 |
| Jun 30, 2022 | -0.33 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.95 |
| Sep 30, 2021 | -2.67 |
| Jun 30, 2021 | -1.12 |